Colleen Cutcliffe is a scientist, entrepreneur, and CEO of Pendulum Therapeutics. She has over 20 years of experience in the biotech, pharma, and academic fields. She is an expert in her analytical skills and problem-solving abilities and has a solid moral compass that guides her decisions.
Cutcliffe was the co-founder and CEO of Pendulum Therapeutics, which develops interventions to target the human microbiome to improve health outcomes. Under her leadership, the company raised $57 million for its research. In addition to this success, she has also been featured on podcasts such as Biotech2050 and Finding Mastery to discuss gut health and probiotics.
Cutcliffe’s expertise extends beyond business; she is also a prominent biochemist who has worked in the pharmaceutical industry for many years. Her work has focused on developing treatments for diseases such as cancer, Alzheimer’s disease, diabetes, and cardiovascular disease. She is passionate about solving complex medical issues that can improve people’s lives.
Cutcliffe is an inspiring leader who sets an example for others with her hard work ethic and dedication to ethical practices. Her commitment to making a difference in the world through science and innovation makes her an invaluable asset to any team or organization she works with.
